Go back
Company Overview
Alvogen is a global, privately owned pharmaceutical company focused on developing, manufacturing and selling generic, brand, over-the-counter brands and biosimilar products for patients around the world.
The company has commercial operations in 35 countries and operates four manufacturing and development hubs in the U.S., Romania, Korea and Taiwan. With a head office in Kiev, Alvogen is one of the fastest growing companies in Ukraine.
200+ |
| |
Generic projects in pipeline |
2800 |
| |
Passionate employees |
35 |
| |
Worldwide offices |
Go back
Purpose driven culture
Our true purpose as a company is to make people’s lives better by producing high quality medicines that help people live longer, healthier and more active lives and making them more accessible to those who might not otherwise afford them. Some of our most recent live changing product launches include the generic alternatives of Tamiflu, Exelon for Alzheimer patients, Velcade for the treatment of cancer, Copaxone for MS patients and the biosimilar Inflectra.
Go back
Giving back
Corporate social responsibility is something that goes to the very core of Alvogen’s philosophy. We are proud of our commitment to the positive impact we have made in our communities through the Alvogen Day of Service and other local charity events and programs. Our goal is to use the power of our brand to promote positive values and contribute to impact the communities we live and work.
Go back
Get in touch
Alvogen Ukraine
Address: 02660, Kyiv, 5-I Brovarsky Avenue
Tel: + 38 044 517 75 00
Patient Safety
If you are a customer and have questions regarding Alvogen medicines, please call The Alvogen Customer Center at Tel + 38 044 517 75 00
Our goal is to ensure that the benefits and risks of a medication are continuously monitored and well-understood by regulators, healthcare providers and patients. Alvogen maintains a pharmacovigilance system, collecting information throughout the lifecycle of each product.